SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes.

Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entire discovery chemistry value chain:
-	Proprietary Screening Libraries including high-sp3 fragments, covalent fragments and macrocycles
-	SpiroKit as turnkey toolboxes for the medicinal chemistry community to speed up research programs
-	Design & Computational Team for fragment-based drug design (FBDD), structure-based drug design (SBDD) and computational-aided drug design (CADD)
-	Medicinal Chemistry group including experts in enabling technologies (photochemistry, photoredox, electrochemistry, biocatalysis, …) to access target molecule faster and explore uncharted chemical space
-	An Early Development division involved in Route Scouting projects to make the bridge between the medicinal chemistry lab and CDMOs
-	Thanks to two-high potent labs, SpiroChem also supports discovery in the field of ADCs (linker-payload chemistry)


Chemicals

Pharmaceutical

Biotechnology

SpiroChem

Thomas Fessard

Anna Wozniak

Florent Beaufils

Gerhard Müller

The Leadership Team at SpiroChem is responsible for setting the strategic vision and direction of the company, ensuring alignment between scientific innovation and business objectives. Comprising the CEO, CFO, COO, and CSO, this team oversees operational efficiency, financial performance, and the advancement of cutting-edge research in discovery chemistry, while fostering collaboration across all divisions to meet client needs and drive growth in the biopharmaceutical and agrochemical sectors.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at SpiroChem

Research and Development